Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis

INTRODUCTION: After stage 3 CKD, the risk of adverse cardiovascular events increased significantly. Therefore, we performed a meta-analysis to investigate the cardiovascular protective effect of SGLT2 inhibitors in patients with stage 3/4 CKD with different baseline kidney function or underlying dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ning, Zhou, Guowei, Zheng, Yawei, Lv, Dan, Zhu, Xiangjun, Wei, Ping, Zheng, Min, Liu, Shijia, Zhou, Enchao, Sun, Wei, Zhang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754287/
https://www.ncbi.nlm.nih.gov/pubmed/35020750
http://dx.doi.org/10.1371/journal.pone.0261986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754287/
https://www.ncbi.nlm.nih.gov/pubmed/35020750
http://dx.doi.org/10.1371/journal.pone.0261986

Ejemplares similares